These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3556014)

  • 1. Imaging techniques and guidelines for evaluation and follow-up of breast cancer patients.
    Feig SA
    Crit Rev Diagn Imaging; 1987; 27(1):1-16. PubMed ID: 3556014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baseline staging tests in primary breast cancer: a practice guideline.
    Myers RE; Johnston M; Pritchard K; Levine M; Oliver T;
    CMAJ; 2001 May; 164(10):1439-44. PubMed ID: 11387916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staging for breast carcinoma.
    Bassett LW; Giuliano AE; Gold RH
    Am J Surg; 1989 Feb; 157(2):250-5. PubMed ID: 2916740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of preoperative bone and liver scans and alkaline phosphatase in the evaluation of breast cancer patients.
    Brar HS; Sisley JF; Johnson RH
    Am J Surg; 1993 Feb; 165(2):221-3; discussion 224. PubMed ID: 8427400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnosis of distant metastases in breast cancer].
    Untucht HJ; Wöllgens P
    Z Allgemeinmed; 1973 Dec; 49(34):1687-9. PubMed ID: 4789422
    [No Abstract]   [Full Text] [Related]  

  • 6. [Breast carcinoma--revision of follow-up recommendations. 2: Special diagnostic value of bone scintigraphy, thoracic radiography, liver ultrasonic, mammography and laboratory tests].
    Sauer H; Hölzel D
    Fortschr Med; 1995 May; 113(14):210-4. PubMed ID: 7607590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence to guidelines for baseline staging in newly diagnosed localized breast cancer.
    DeMiglio L; Murdoch V; Ivison J; Voutsadakis IA
    Cancer Treat Res Commun; 2020; 22():100160. PubMed ID: 31677495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of bone and liver scans in surveying patients with breast cancer for metastatic disease.
    Evans DM; Wright DJ
    Am Surg; 1987 Oct; 53(10):603-5. PubMed ID: 2823653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Imaging diagnosis of non-lymph node metastasis of bladder carcinoma].
    Altieri V; Setola P; Ottaviano N; Ucciero G; Scognamiglio G; Montanaro V; Giannella R; Rega A; Lotti T
    Arch Ital Urol Androl; 1994 Dec; 66(5):223-8. PubMed ID: 7812300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Horner's syndrome: an ominous sign in breast cancer.
    Tjalma WA
    Eur J Obstet Gynecol Reprod Biol; 2006 Jun; 126(2):270-1. PubMed ID: 16412554
    [No Abstract]   [Full Text] [Related]  

  • 11. [Staging of pulmonary cancer, establishment of M1].
    Schnyder P
    Schweiz Med Wochenschr; 1987 Sep; 117(39):1475-80. PubMed ID: 3672084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency and distribution pattern of distant metastases in breast cancer patients at the time of primary presentation.
    Schneider C; Fehr MK; Steiner RA; Hagen D; Haller U; Fink D
    Arch Gynecol Obstet; 2003 Nov; 269(1):9-12. PubMed ID: 14605816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensive diagnostic follow-up after treatment of primary breast cancer. A randomized trial. National Research Council Project on Breast Cancer follow-up.
    Rosselli Del Turco M; Palli D; Cariddi A; Ciatto S; Pacini P; Distante V
    JAMA; 1994 May; 271(20):1593-7. PubMed ID: 7848404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole-body MRI for metastases screening: a preliminary study using 3D VIBE sequences with automatic subtraction between noncontrast and contrast enhanced images.
    Thomson V; Pialat JB; Gay F; Coulon A; Voloch A; Granier A; Guérin JC; Viallon M; Berthezene Y
    Am J Clin Oncol; 2008 Jun; 31(3):285-92. PubMed ID: 18525309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A National Study of the Use of Asymptomatic Systemic Imaging for Surveillance Following Breast Cancer Treatment (AFT-01).
    Schumacher JR; Neuman HB; Chang GJ; Kozower BD; Edge SB; Yu M; Vanness DJ; Si Y; Jacobs EA; Francescatti AB; Spears PA; Havlena J; Adesoye T; McKellar D; Winchester D; Burnside ES; Greenberg CC;
    Ann Surg Oncol; 2018 Sep; 25(9):2587-2595. PubMed ID: 29777402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tailoring distant metastatic imaging for patients with clinically localized undifferentiated nasopharyngeal carcinoma.
    Kumar MB; Lu JJ; Loh KS; Chong LM; Soo R; Goh BC; Tan KS; Shakespeare TP
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):688-93. PubMed ID: 14967421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How far investigations for occult metastases in breast cancer aid the clinician.
    Glynne-Jones R; Young T; Ahmed A; Ell PJ; Berry RJ
    Clin Oncol (R Coll Radiol); 1991 Mar; 3(2):65-72. PubMed ID: 2031885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of intensive follow-up testing in breast cancer cases.
    Roselli Del Turco M; Palli D; Cariddi A; Ciatto S; Pacini P; Distante V
    Ann Oncol; 1995; 6 Suppl 2():37-9. PubMed ID: 8547195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alkaline phosphatase isoenzymes in detection and follow up of breast cancer metastases.
    Ritzke C; Stieber P; Untch M; Nagel D; Eiermann W; Fateh-Moghadam A
    Anticancer Res; 1998; 18(2B):1243-9. PubMed ID: 9615795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening tests to evaluate distant metastases in head and neck cancer.
    Ferlito A; Buckley JG; Rinaldo A; Mondin V
    ORL J Otorhinolaryngol Relat Spec; 2001; 63(4):208-11. PubMed ID: 11408813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.